337 related articles for article (PubMed ID: 8776365)
1. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis.
Haroon TS; Hussain I; Aman S; Jahangir M; Kazmi AH; Sami AR; Nagi AH; Alvi KH; Iqbal N; Khan KA; Aziz R
Br J Dermatol; 1996 Jul; 135(1):86-8. PubMed ID: 8776365
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine.
Ungpakorn R; Ayutyanont T; Reangchainam S; Supanya S
Clin Exp Dermatol; 2004 May; 29(3):300-3. PubMed ID: 15115516
[TBL] [Abstract][Full Text] [Related]
4. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
Rademaker M; Havill S
N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
[TBL] [Abstract][Full Text] [Related]
5. Tinea capitis caused by Microsporum canis treated with terbinafine.
Aste N; Pau M
Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
7. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
Fleece D; Gaughan JP; Aronoff SC
Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
[TBL] [Abstract][Full Text] [Related]
8. An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans.
Ergin S; Ergin C; Erdoğan BS; Kaleli I; Evliyaoğlu D
Clin Exp Dermatol; 2006 Mar; 31(2):212-4. PubMed ID: 16487093
[TBL] [Abstract][Full Text] [Related]
9. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children.
Dragos V; Lunder M
Pediatr Dermatol; 1997; 14(1):46-8. PubMed ID: 9050765
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis.
Jahangir M; Hussain I; Ul Hasan M; Haroon TS
Br J Dermatol; 1998 Oct; 139(4):672-4. PubMed ID: 9892912
[TBL] [Abstract][Full Text] [Related]
11. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
[TBL] [Abstract][Full Text] [Related]
12. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
Dastghaib L; Azizzadeh M; Jafari P
J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
[TBL] [Abstract][Full Text] [Related]
16. The use of oral terbinafine (Lamisil) in children.
Krafchik B; Pelletier J
Dermatology; 1997; 194 Suppl 1():43-4. PubMed ID: 9154402
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study.
Friedlander SF; Aly R; Krafchik B; Blumer J; Honig P; Stewart D; Lucky AW; Gupta AK; Babel DE; Abrams B; Gourmala N; Wraith L; Paul C;
Pediatrics; 2002 Apr; 109(4):602-7. PubMed ID: 11927703
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
[TBL] [Abstract][Full Text] [Related]
19. Oral terbinafine for tinea capitis due to Microsporum canis in children.
Baleviciene G; Ceburkovas O; Maciuliene D
Acta Derm Venereol; 2001; 81(1):61. PubMed ID: 11411922
[No Abstract] [Full Text] [Related]
20. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
